These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 29526709)

  • 21. Mechanistic Insight into the Design of Chemical Tools to Control Multiple Pathogenic Features in Alzheimer's Disease.
    Han J; Du Z; Lim MH
    Acc Chem Res; 2021 Oct; 54(20):3930-3940. PubMed ID: 34606227
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Colorimetric Detection of Mutant β-Amyloid(1-40) Membrane-Active Aggregation with Biosensing Vesicles.
    Dorsey MP; Nguelifack BM; Yates EA
    ACS Appl Bio Mater; 2019 Nov; 2(11):4966-4977. PubMed ID: 35021496
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The heterogeneous nature of Cu2+ interactions with Alzheimer's amyloid-β peptide.
    Drew SC; Barnham KJ
    Acc Chem Res; 2011 Nov; 44(11):1146-55. PubMed ID: 21714485
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Secondary structure and interfacial aggregation of amyloid-beta(1-40) on sodium dodecyl sulfate micelles.
    Rangachari V; Reed DK; Moore BD; Rosenberry TL
    Biochemistry; 2006 Jul; 45(28):8639-48. PubMed ID: 16834338
    [TBL] [Abstract][Full Text] [Related]  

  • 25. α-Sheet secondary structure in amyloid β-peptide drives aggregation and toxicity in Alzheimer's disease.
    Shea D; Hsu CC; Bi TM; Paranjapye N; Childers MC; Cochran J; Tomberlin CP; Wang L; Paris D; Zonderman J; Varani G; Link CD; Mullan M; Daggett V
    Proc Natl Acad Sci U S A; 2019 Apr; 116(18):8895-8900. PubMed ID: 31004062
    [TBL] [Abstract][Full Text] [Related]  

  • 26. α-synuclein-assisted oligomerization of β-amyloid (1-42).
    Chau E; Kim JR
    Arch Biochem Biophys; 2022 Mar; 717():109120. PubMed ID: 35041853
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Amyloid β-protein oligomers promote the uptake of tau fibril seeds potentiating intracellular tau aggregation.
    Shin WS; Di J; Cao Q; Li B; Seidler PM; Murray KA; Bitan G; Jiang L
    Alzheimers Res Ther; 2019 Oct; 11(1):86. PubMed ID: 31627745
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neuropathology and biochemistry of Aβ and its aggregates in Alzheimer's disease.
    Thal DR; Walter J; Saido TC; Fändrich M
    Acta Neuropathol; 2015 Feb; 129(2):167-82. PubMed ID: 25534025
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The coexistence of an equal amount of Alzheimer's amyloid-β 40 and 42 forms structurally stable and toxic oligomers through a distinct pathway.
    Chang YJ; Chen YR
    FEBS J; 2014 Jun; 281(11):2674-87. PubMed ID: 24720730
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Formation of dynamic soluble surfactant-induced amyloid β peptide aggregation intermediates.
    Abelein A; Kaspersen JD; Nielsen SB; Jensen GV; Christiansen G; Pedersen JS; Danielsson J; Otzen DE; Gräslund A
    J Biol Chem; 2013 Aug; 288(32):23518-28. PubMed ID: 23775077
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular mechanisms of amyloid-β peptide fibril and oligomer formation: NMR-based challenges.
    Hiroaki H
    Biophys Physicobiol; 2023; 20(1):e200007. PubMed ID: 37234855
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Structures and dynamics of β-barrel oligomer intermediates of amyloid-beta16-22 aggregation.
    Ge X; Sun Y; Ding F
    Biochim Biophys Acta Biomembr; 2018 Sep; 1860(9):1687-1697. PubMed ID: 29550287
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Physiologically-relevant levels of sphingomyelin, but not GM1, induces a β-sheet-rich structure in the amyloid-β(1-42) monomer.
    Owen MC; Kulig W; Poojari C; Rog T; Strodel B
    Biochim Biophys Acta Biomembr; 2018 Sep; 1860(9):1709-1720. PubMed ID: 29626441
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of Pairs of Toxic and Nontoxic Misfolded Protein Oligomers Elucidates the Structural Determinants of Oligomer Toxicity in Protein Misfolding Diseases.
    Limbocker R; Cremades N; Cascella R; Tessier PM; Vendruscolo M; Chiti F
    Acc Chem Res; 2023 Jun; 56(12):1395-1405. PubMed ID: 37071750
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alzheimer's disease.
    De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
    Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fibrillar seeds alleviate amyloid-β cytotoxicity by omitting formation of higher-molecular-weight oligomers.
    Wu WH; Liu Q; Sun X; Yu JS; Zhao DS; Yu YP; Luo JJ; Hu J; Yu ZW; Zhao YF; Li YM
    Biochem Biophys Res Commun; 2013 Sep; 439(3):321-6. PubMed ID: 24012671
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ex situ atomic force microscopy analysis of beta-amyloid self-assembly and deposition on a synthetic template.
    Ha C; Park CB
    Langmuir; 2006 Aug; 22(16):6977-85. PubMed ID: 16863248
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preparation protocols of aβ(1-40) promote the formation of polymorphic aggregates and altered interactions with lipid bilayers.
    Yates EA; Legleiter J
    Biochemistry; 2014 Nov; 53(45):7038-50. PubMed ID: 25349919
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Two types of Alzheimer's beta-amyloid (1-40) peptide membrane interactions: aggregation preventing transmembrane anchoring versus accelerated surface fibril formation.
    Bokvist M; Lindström F; Watts A; Gröbner G
    J Mol Biol; 2004 Jan; 335(4):1039-49. PubMed ID: 14698298
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Large Soluble Oligomers of Amyloid β-Protein from Alzheimer Brain Are Far Less Neuroactive Than the Smaller Oligomers to Which They Dissociate.
    Yang T; Li S; Xu H; Walsh DM; Selkoe DJ
    J Neurosci; 2017 Jan; 37(1):152-163. PubMed ID: 28053038
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.